• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗期间患者在线自我报告毒性症状。

Patient online self-reporting of toxicity symptoms during chemotherapy.

作者信息

Basch Ethan, Artz David, Dulko Dorothy, Scher Kevin, Sabbatini Paul, Hensley Martee, Mitra Nandita, Speakman John, McCabe Mary, Schrag Deborah

机构信息

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 307 E 63rd St, New York, NY 10021, USA.

出版信息

J Clin Oncol. 2005 May 20;23(15):3552-61. doi: 10.1200/JCO.2005.04.275.

DOI:10.1200/JCO.2005.04.275
PMID:15908666
Abstract

PURPOSE

Tracking symptoms related to treatment toxicity is standard practice in routine care and during clinical trials. Currently, clinicians collect symptom information via complex and often inefficient mechanisms, but there is growing interest in collecting outcome information directly from patients.

PATIENTS AND METHODS

The National Cancer Institute Common Terminology Criteria for Adverse Events schema for seven common symptoms was adapted into a Web-based patient-reporting system, accessible from desktop computers in outpatient clinics and from home computers. Eighty patients with gynecologic malignancies beginning standard chemotherapy regimens were enrolled between April and September 2004. During an 8-week observation period, participants were encouraged to log in and report symptoms at each follow-up visit, or alternatively, to access the system from home.

RESULTS

All patients completed an initial log in. At each subsequent appointment, most enrollees (80% to 85%) reported symptoms using the online system, with a mean of three follow-up visits per patient during the observation period (range, one to six). Sixty of 80 patients (75%) logged in at least once from home. Use was significantly associated with prior Internet experience. Forty-two severe toxicities (grade 3 to 4) entered from home prompted seven clinician interventions. Most patients (96%) found the system useful and would recommend it to others.

CONCLUSION

Patients are capable of reporting symptoms experienced during chemotherapy using a Web-based interface. Assessment in the clinical trial setting and comparison of direct patient- versus clinician-based approaches for reporting symptoms and their severity are warranted.

摘要

目的

在常规护理和临床试验中,追踪与治疗毒性相关的症状是标准做法。目前,临床医生通过复杂且往往效率低下的机制收集症状信息,但直接从患者那里收集结果信息的兴趣日益浓厚。

患者与方法

美国国立癌症研究所不良事件通用术语标准中关于七种常见症状的模式被改编成一个基于网络的患者报告系统,可从门诊诊所的台式电脑以及家用电脑访问。2004年4月至9月期间,招募了80名开始接受标准化化疗方案的妇科恶性肿瘤患者。在为期8周的观察期内,鼓励参与者在每次随访就诊时登录并报告症状,或者也可以在家中访问该系统。

结果

所有患者都完成了首次登录。在随后的每次预约就诊时,大多数登记者(80%至85%)使用在线系统报告症状,观察期内每位患者平均随访就诊三次(范围为一至六次)。80名患者中有60名(75%)至少在家中登录过一次。使用情况与先前的互联网使用经验显著相关。从家中输入的42例严重毒性反应(3至4级)促使临床医生进行了7次干预。大多数患者(96%)认为该系统有用,并会向他人推荐。

结论

患者能够使用基于网络的界面报告化疗期间经历的症状。有必要在临床试验环境中进行评估,并比较直接基于患者和基于临床医生的报告症状及其严重程度的方法。

相似文献

1
Patient online self-reporting of toxicity symptoms during chemotherapy.化疗期间患者在线自我报告毒性症状。
J Clin Oncol. 2005 May 20;23(15):3552-61. doi: 10.1200/JCO.2005.04.275.
2
Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy.通过电子患者报告结局对接受化疗的患者进行长期毒性监测。
J Clin Oncol. 2007 Dec 1;25(34):5374-80. doi: 10.1200/JCO.2007.11.2243.
3
Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.在一项2期癌症治疗试验期间,与临床研究人员共享患者报告的症状毒性和体能状态的可行性及临床影响。
Clin Trials. 2016 Jun;13(3):331-7. doi: 10.1177/1740774515615540. Epub 2015 Nov 4.
4
Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy.在家中通过互联网进行常规化疗期间长期患者自我报告毒性的可行性。
J Clin Oncol. 2013 Jul 10;31(20):2580-5. doi: 10.1200/JCO.2012.47.6804. Epub 2013 Jun 3.
5
Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities.评估一个用于癌症患者自我报告化疗毒性的在线平台。
J Am Med Inform Assoc. 2007 May-Jun;14(3):264-8. doi: 10.1197/jamia.M2177. Epub 2007 Feb 28.
6
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.在癌症门诊患者中使用通用不良事件术语标准和其他患者报告症状结局工具进行常规评估的可接受性:玛格丽特公主癌症中心的经验。
Oncologist. 2019 Nov;24(11):e1219-e1227. doi: 10.1634/theoncologist.2018-0830. Epub 2019 Aug 13.
7
How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.临床医生对化疗不良反应的报告有多准确?与来自生活质量问卷C30的患者报告症状的比较。
J Clin Oncol. 2004 Sep 1;22(17):3485-90. doi: 10.1200/JCO.2004.03.025.
8
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.使用美国国立癌症研究所不良事件通用术语标准的患者与临床医生症状报告:一项基于问卷的研究结果
Lancet Oncol. 2006 Nov;7(11):903-9. doi: 10.1016/S1470-2045(06)70910-X.
9
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.抗癌治疗期间出现的有症状毒性:三项随机试验中患者报告和医生报告的一致性。
J Clin Oncol. 2015 Mar 10;33(8):910-5. doi: 10.1200/JCO.2014.57.9334. Epub 2015 Jan 26.
10
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.多中心癌症临床试验中患者报告症状性不良事件的可行性评估。
JAMA Oncol. 2017 Aug 1;3(8):1043-1050. doi: 10.1001/jamaoncol.2016.6749.

引用本文的文献

1
Comparative effectiveness of remote perioperative telemonitoring in cancer surgery: a randomized trial.癌症手术中远程围手术期远程监测的比较效果:一项随机试验。
NPJ Digit Med. 2025 Aug 28;8(1):555. doi: 10.1038/s41746-025-01961-z.
2
ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled Trial.ENABLE:基于应用程序的乳腺癌患者报告的生活质量、不良事件及治疗满意度的数字采集与干预:一项随机对照试验方案
JMIR Res Protoc. 2025 May 26;14:e69855. doi: 10.2196/69855.
3
Patients' acceptability of a patient-reported outcome measure in cardiac rehabilitation (the PRO-Heart-DK)-a mixed methods study using the Theoretical Framework of Acceptability.
患者对心脏康复中患者报告结局量表(PRO-Heart-DK)的可接受性——一项运用可接受性理论框架的混合方法研究
J Patient Rep Outcomes. 2025 Mar 25;9(1):35. doi: 10.1186/s41687-024-00831-8.
4
A Pilot Study on the Collection of Adverse Event Data from the Patient Using an Electronic Platform in a Cancer Clinical Trial Unit.在癌症临床试验单位使用电子平台从患者收集不良事件数据的一项试点研究。
Drugs Real World Outcomes. 2024 Dec;11(4):725-734. doi: 10.1007/s40801-024-00461-y. Epub 2024 Nov 2.
5
Implementation of an electronic prospective surveillance model for cancer rehabilitation: a mixed methods study protocol.实施癌症康复电子前瞻性监测模型:混合方法研究方案。
BMJ Open. 2024 Sep 20;14(9):e090449. doi: 10.1136/bmjopen-2024-090449.
6
Introduction and validation of the open symptom framework: a public domain modular framework for patient-reported measurement of symptoms related to cancer and its treatment.引言和开放式症状框架的验证:一个用于患者报告癌症及其治疗相关症状的公共领域模块化框架。
Qual Life Res. 2024 Sep;33(9):2349-2358. doi: 10.1007/s11136-024-03656-6. Epub 2024 Jul 18.
7
Usability and Preliminary Efficacy of an Adaptive Supportive Care System for Patients With Cancer: Pilot Randomized Controlled Trial.癌症患者适应性支持照护系统的可用性及初步疗效:随机对照试验试点研究
JMIR Cancer. 2024 Jul 10;10:e49703. doi: 10.2196/49703.
8
Challenges in the implementation of electronic systems for patient report of symptoms in oncology: a scoping review.肿瘤学中患者症状报告电子系统实施的挑战:一项范围综述
J Hosp Manag Health Policy. 2021;5. doi: 10.21037/jhmhp-20-108. Epub 2021 Sep 25.
9
Engagement Among Diverse Patient Backgrounds in a Remote Symptom Monitoring Program.不同患者背景人群在远程症状监测项目中的参与情况。
JCO Oncol Pract. 2024 Oct;20(10):1426-1435. doi: 10.1200/OP.24.00066. Epub 2024 Jun 25.
10
Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevance.基于基因型的伊立替康剂量指导下的纵向患者报告结局:可行性和临床相关性。
Oncologist. 2024 Sep 6;29(9):780-785. doi: 10.1093/oncolo/oyae121.